皇冠体育app

皇冠体育app MHRA has today issued precautionary safety advice regarding possible contamination of certain eye gels and has told patients and users of the affected products to stop using them immediately. 皇冠体育appy should return their product to the place of purchase.

Anyone feeling unwell, for example with symptoms of eye infection, such as reduced vision, red and painful eye, should contact a healthcare professional and tell them that they have been using a recalled eye gel.

皇冠体育appse types of products are known as carbomer-containing eye gels and are generally used to relieve the symptoms of dry eye. Those branded Aacarb, Aacomer and Puroptics, have a potential risk of microbial contamination, which can cause an infection if the gel is used.

Investigations are ongoing to determine if there is a link between the infections which have been identified and these products. 皇冠体育app action is being taken as a precaution, and the risk to the general public is considered to be low.

Alison Cave, MHRA Chief Safety Officer, comments:

鈥淲hilst the risk to users is low, we are taking precautionary action.

鈥淎ll users of the affected products should stop using them immediately and return them to their supplier or retailer.

鈥淚f you have been using these gels, and if your eye symptoms worsen or you are worried about your health, please contact your healthcare professional, and tell them you have been using an eye gel that has been recalled.

鈥淩etailers should, where possible, contact patients who have been dispensed any of the affected batches and ask them to return the product.

鈥淲e are working very closely with our colleagues at UKHSA and will issue further advice to protect patients and the public, if needed.鈥�

Individuals with cystic fibrosis and patients with certain risk factors, are at higher risk of adverse effects from Burkholderia cenocepacia - the bacteria which may have caused the microbial contamination. As a precautionary measure, and until further information is available, the UK Health Security Agency (UKHSA) is additionally recommending that all carbomer-containing lubricating eye gels are avoided where possible in individuals with cystic fibrosis, patients being cared for in critical care settings (e.g. intensive care), those who are severely immunocompromised and in hospital, and patients awaiting lung transplantation.

皇冠体育app issue was identified as part of an ongoing investigation conducted by UKHSA after a small number of cases of infection were identified. UKHSA and MHRA investigations are ongoing and are not conclusive.

皇冠体育app MHRA is urging healthcare professionals, or anyone who suspects they may have become unwell after using these eye gels, to report it the agency鈥檚 .

Ends

Notes to editors:

1. 皇冠体育app MHRA鈥檚 Device Safety Information notice is available here.
2. 皇冠体育app manufacturer鈥檚 issued to its customers is available here.
3. Images of the products affected are available .
4. 皇冠体育app Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe.鈥� All our work is underpinned by robust and fact-based judgements to ensure that the benefits justify any risks.
5. 皇冠体育app MHRA is an executive agency of the Department of Health and Social Care.
6. For media enquiries, please contact the聽[email protected], or call on 020 3080 7651.